Comparative Antidote Efficacy

Comparative Antidote Efficacy is a metric that quantifies the relative effectiveness of fomepizole versus alternative antidotes in mitigating toxicological outcomes within controlled clinical or experimental settings.

7

Publications

577

Citations

35

Authors

16

Institutions

Publications per year

2017–2026

0

Authors

35

  1. BS
    Boris Sobolev

    University of British Columbia, Canada

    1 publications · 78 citations

    1

    h-index

  2. DW
    Dylan W. de Lange

    University Medical Center Utrecht, Netherlands

    1 publications · 78 citations

    1

    h-index

  3. DG
    Donald G. Barceloux

    University of California, Los Angeles, United States

    1 publications · 336 citations

    1

    h-index

  4. KJ
    Katherine J. Lepik

    University of British Columbia, Canada

    1 publications · 78 citations

    1

    h-index

  5. AR
    A.G. Rauws

    National Institute for Public Health and the Environment, Netherlands

    1 publications · 20 citations

    1

    h-index

1–5 of 35

Venues

  1. Dermatologic Surgery

    1 publications · 23 citations

    1

    h-index

  2. PubMed

    Repository · 1 publications · 78 citations

    1

    h-index

  3. European Journal of Clinical Pharmacology

    1 publications · 20 citations

    1

    h-index

  4. Journal of Toxicology Clinical Toxicology

    1 publications · 336 citations

    1

    h-index

  5. European Journal of Emergency Medicine

    1 publications · 21 citations

    1

    h-index

1–5